Dopamine promotes the neurodegenerative potential of β‐synuclein

2020 | journal article; research paper. A publication with affiliation to the University of Göttingen.

Jump to:Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Dopamine promotes the neurodegenerative potential of β‐synuclein​
Raina, A.; Leite, K.; Guerin, S.; Mahajani, S. U.; Chakrabarti, K. S.; Voll, D. & Becker, S.  et al.​ (2020) 
Journal of Neurochemistry156(5) pp. 674​-691​.​ DOI: 


Raina, Anupam; Leite, Kristian; Guerin, Sofia; Mahajani, Sameehan U.; Chakrabarti, Kalyan S.; Voll, Diana; Becker, Stefan ; Griesinger, Christian ; Bähr, Mathias ; Kügler, Sebastian 
A contribution of α-Synuclein (α-Syn) to etiology of Parkinson´s disease (PD) and Dementia with Lewy bodies (DLB) is currently undisputed, while the impact of the closely related β-Synuclein (β-Syn) on these disorders remains enigmatic. β-Syn has long been considered to be an attenuator of the neurotoxic effects of α-Syn, but in a rodent model of PD β-Syn induced robust neurodegeneration in dopaminergic neurons of the substantia nigra. Given that dopaminergic nigral neurons are selectively vulnerable to neurodegeneration in PD, we now investigated if dopamine can promote the neurodegenerative potential of β-Syn. We show that in cultured rodent and human neurons a dopaminergic neurotransmitter phenotype substantially enhanced β-Syn-induced neurodegeneration, irrespective if dopamine is synthesized within neurons or up-taken from extracellular space. Nuclear magnetic resonance interaction and thioflavin-T incorporation studies demonstrated that dopamine and its oxidized metabolites 3,4-dihydroxyphenylacetaldehyde (DOPAL) and dopaminochrome (DCH) directly interact with β-Syn, thereby enabling structural and functional modifications. Interaction of DCH with β-Syn inhibits its aggregation, which might result in increased levels of neurotoxic oligomeric β-Syn. Since protection of outer mitochondrial membrane integrity prevented the additive neurodegenerative effect of dopamine and β-Syn, such oligomers might act at a mitochondrial level similar to what is suggested for α-Syn. In conclusion, our results suggest that β-Syn can play a significant pathophysiological role in etiology of PD through its interaction with dopamine metabolites and thus should be re-considered as a disease-relevant factor, at least for those symptoms of PD that depend on degeneration of nigral dopaminergic neurons.
Issue Date
Journal of Neurochemistry 
EXC 2067: Multiscale Bioimaging 
Working Group
RG Bähr (Neurobiological Research Laboratory) 
RG Griesinger 
External URL



Social Media